StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence gross margin

Gross margin is gross profit as a percentage of revenue.

Bio Essence's gross margin for the twelve months ending Sep 30, 2026 was 68.4%. For fiscal 2025 it was 75.3%, against 67.0% the year before. The highest annual figure on record is 75.3% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202575.3%+8.3
FY2024Dec 31, 202467.0%+16.7
FY2023Dec 31, 202350.3%−2.5
FY2022Dec 31, 202252.8%+19.2
FY2021Dec 31, 202133.6%+9.9
FY2020Dec 31, 202023.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202655.0%−15.0
Q2 FY2026Jun 30, 202659.2%−5.9
Q1 FY2026Mar 31, 202663.8%−29.0
Q4 FY2025Dec 31, 202577.3%+4.8
Q3 FY2025Sep 30, 202570.0%+9.9
Q2 FY2025Jun 30, 202565.1%−4.9
Q1 FY2025Mar 31, 202592.8%+79.8
Q4 FY2024Dec 31, 202472.4%+30.2
Q3 FY2024Sep 30, 202460.1%+11.3
Q2 FY2024Jun 30, 202470.0%+63.0
Q3 FY2023Sep 30, 202313.0%−32.0
Q2 FY2023Jun 30, 202342.3%−12.4
Q1 FY2023Mar 31, 202348.8%+25.8
Q4 FY2022Dec 31, 20227.0%−21.9
Q3 FY2022Sep 30, 202245.0%+3.0
Q2 FY2022Jun 30, 202254.6%+27.3
Q1 FY2022Mar 31, 202223.0%−13.2
Q4 FY2021Dec 31, 202129.0%+57.3
Q3 FY2021Sep 30, 202142.0%+5.7
Q2 FY2021Jun 30, 202127.3%−2.1
Q1 FY2021Mar 31, 202136.2%−11.5
Q4 FY2020Dec 31, 2020-28.3%–
Q3 FY2020Sep 30, 202036.3%–
Q2 FY2020Jun 30, 202029.4%–
Q1 FY2020Mar 31, 202047.7%–

More Bio Essence figures

See a number that looks wrong?